Fortrea Holdings (FTRE) Other Working Capital Changes (2022 - 2026)
Fortrea Holdings (FTRE) posted Other Working Capital Changes of $6.6 million for Q1 2026, down 89.04% on a QoQ basis from $60.2 million in Q4 2025, and down 36.54% year-over-year from $10.4 million in Q1 2025.
Fortrea Holdings (FTRE) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Fortrea Holdings' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- Quarterly Other Working Capital Changes fell 36.54% year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111.0 million (down 10.48% YoY) and the FY2025 annual result came in at $114.8 million, down 18.0% from the prior year.
- Other Working Capital Changes was $6.6 million for Q1 2026 at Fortrea Holdings, down from $60.2 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $44.8 million in Q4 2024 and bottomed at -$19.3 million in Q3 2025.
- A 5-year average of $2.5 million and a median of -$1.9 million in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 14540.0% — and 2025, when it tumbled 60.61%.
- Fortrea Holdings' Other Working Capital Changes stood at $8.2 million in 2022, then slumped by 53.66% to $3.8 million in 2023, then soared by 784.21% to $33.6 million in 2024, then surged by 79.17% to $60.2 million in 2025, then plunged by 89.04% to $6.6 million in 2026.
- Business Quant data shows FTRE's Other Working Capital Changes at $6.6 million in Q1 2026, $60.2 million in Q4 2025, and $31.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.40 Mn |
| Mar 31, 2026 | -11.40 Mn |
| Mar 31, 2026 | -11.40 Mn |
| Dec 31, 2025 | 11.40 Mn |
| Dec 31, 2025 | 11.40 Mn |
| Dec 31, 2025 | 11.40 Mn |
| Sep 30, 2025 | -19.30 Mn |
| Sep 30, 2025 | -19.30 Mn |
| Sep 30, 2025 | -19.30 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Mar 31, 2025 | -17.60 Mn |
| Mar 31, 2025 | -17.60 Mn |
| Mar 31, 2025 | -17.60 Mn |
| Dec 31, 2024 | 44.80 Mn |
| Dec 31, 2024 | 44.80 Mn |
| Dec 31, 2024 | 44.80 Mn |
| Sep 30, 2024 | 21.60 Mn |
| Sep 30, 2024 | 21.60 Mn |